Related Experiment Video

Updated: May 16, 2026

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Molecular targeted therapy in lung cancer

Naomi Fujioka1, Peter B Bitterman

  • 1Department of Medicine, Masonic Cancer Center, University of Minnesota, USA.

Minnesota Medicine
|December 1, 2012
PubMed

Insights

Genetic sequencing advances non-small cell lung cancer (NSCLC) understanding, improving diagnosis and targeted therapy. Research explores mutations in never-smokers and Minnesota

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Non-small cell lung cancer (NSCLC) treatment has advanced due to genetic sequencing.
  • Targeted therapies offer improved outcomes for NSCLC patients.
  • Understanding specific genetic mutations is crucial for effective treatment.

Purpose of the Study:

  • To review past and ongoing targeted therapy studies for lung cancer.
  • To investigate genetic mutations in NSCLC among never-smokers.
  • To highlight the contributions of Minnesota researchers to lung cancer pathogenesis.

Main Methods:

  • Review of existing literature on targeted lung cancer therapies.
  • Analysis of genetic sequencing data from NSCLC patients, particularly never-smokers.
  • Examination of research conducted by Minnesota-based institutions.

Main Results:

  • Genetic sequencing has enhanced the diagnosis and treatment of NSCLC.
  • Specific genetic mutations are identified in lung cancers occurring in individuals without a smoking history.
  • Minnesota researchers play a significant role in advancing lung cancer research.

Conclusions:

  • Targeted therapies, guided by genetic insights, are transforming NSCLC care.
  • Further research into NSCLC pathogenesis, especially in never-smokers, is essential.
  • The work of Minnesota researchers contributes significantly to the field of lung cancer.

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...